Recombinant Pseudomonas exoenzyme S and exoenzyme S from Pseudomonas aeruginosa DG1 share the ability to stimulate T lymphocyte proliferation

Canadian Journal of Microbiology

Volumn 45, Issue 7, 1999, Pages 607-611

  Bruno, Tony F ^a   Woods, Donald E ^a   Storey, Douglas G ^a   Mody, Christopher H ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cystic fibrosis; Exoenzyme S; Pseudomonas aeruginosa; T lymphocyte

Indexed keywords

BACTERIAL DNA; BACTERIAL ENZYME; EPITOPE; EXOENZYME S; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; CELL POPULATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA SYNTHESIS; FLOW CYTOMETRY; HOSPITAL INFECTION; IMMUNOBLOTTING; INFLAMMATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; T LYMPHOCYTE ACTIVATION;

EID: 0033306494     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/w99-044     Document Type: Article

References (27)

1. Bruno, T.F., Buser, D.E., Syme, R.M., Woods, D.E., and Mody, C.H. 1998. Pseudomonas aeruginosa exoenzyme S is a mitogen but not a superantigen for human T lymphocytes. Infect. Immun. 66: 3072-3079.
2. Coburn, J., and Gill, D.M. 1991. ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 59: 4259-4262.
3. Gilligan, P.H. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Microbiol. Rev. 4: 35-51.
4. Goranson, J., and Frank, D.W. 1996. Genetic analysis of exoenzyme S by Pseudomonas aeruginosa. FEMS. Microbiol. Lett. 135: 149-155.
5. Grimwood, K., To, M., Semple, R.A., Rabin, H.R., Sokol, P.A., and Woods, D.E. 1993. Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr. Pulmonol. 15: 135-139.
6. Gross PA. 1987. Epidemiology of hospital-acquired pneumonia. Semin. Respir. Infect. 2: 2-7.
7. Henderson, B., Wilson, M., and Wren, B. 1997. Are bacterial exotoxins cytokine network regulators? Trends Microbiol. 5: 454-458.
8. Knight, D.A., and Barbieri, J.T. 1997. Ecto-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 65: 3304-3309.
9. Knight, D.A., Finck-Babancon, V., Kulich, S.M., and Barbieri, J.T. 1995. Functional domains of Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 63: 3182-3186.
10. Kotzin, B.L., Leung, D.Y.M., Kappler, J., and Marrack, P. 1993. Superantigens and their role in human disease. Adv. Immunol. 54: 99-165.
11. Kudoh, I., Weiner-Kronish, J.P., Hashimoto, S., Pittet, J., and Frank, D.W. 1994. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am. J. Physiol. 267: L551-L556.
12. Kulich, S., Frank, D.W., and Barbieri, J.T. 1995. Expression of recombinant exoenzyme S of Pseudomonas aeruginosa. Infect. Immun. 63: 1-8.
13. Markham, R.B., Goellner, J., and Pier, G.B. 1984. In vitro T cell-mediated killing of Pseudomonas aeruginosa. I. Evidence that a lymphokine mediates killing. J. Immunol. 133: 962-968.
14. Markham, R.B., Pier, G.B., Goellner, J.L., and Mizel, S.B. 1985. In vitro T cell mediated killing of Pseudomonas aeruginosa. II. The role of macrophages and T cell subsets in T cell killing. J. Immunol. 134: 4112-4117.
15. Miethke, T., Wahl, C., Regele, D., Gaus, H., Heeg, K., and Wagner, H. 1993. Superantigen mediated shock: a cytokine release syndrome. Immunobiol. 189: 270-284.
16. Mody, C.H., Buser, D.E., Syme, R.M., and Woods D.E. 1995. Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes. Infect. Immun. 63: 1800-1805.
17. Morrison, A.J., and Wenzel, R.P. 1994. Epidemiology of infections due to Pseudomonas aeruginosa. Rev. Infect. Dis. 6: S627-S642.
18. Nicas, T.I., Frank, D.W., Stenzel, P., Lile, J.D., and Iglewski, B.H. 1985. Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections. Eur. J. Clin. Microbiol. 4: 175-179.
19. Olson, J.C., McGuffie, E.M., and Frank, D.W. 1997. Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells. Infect. Immun. 65: 248-256.
20. Porwoll, J.M., Gebel, H.M., Rodey, G.E., and Markham, R.B. 1983. In vitro response of human T cells to Pseudomonas aeruginosa. Infect. Immun. 40: 670-674.
21. Powderly, W.G., Pier, G.B., and Markham, R.B. 1986. T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice. J. Clin. Invest. 78: 375-380.
22. Testi, R., Phillips, J.H., and Lanier, L.L. 1989. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor signalling. J. Immunol. 142: 1854-1860.
23. Woods, D.E., and Que, J.U. 1987. Purification of Pseudomonas aeruginosa exoenzyme S. Infect. Immun. 55: 579-586.
24. Woods, D.E., and Sokol, P.A. 1985. Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Psuedomonas aeruginosa. Eur. J. Clin. Microbiol. 4: 163-169.
25. Woods, D.E., Schaffer, M.S., Rabin, H.R., Campbell, G.D., and Sokol, P.A. 1986. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J. Clin. Microbiol. 4: 260-264.
26. Woods, D.E., Hwang, W.S., Shahrabadi, M.S., and Que, J.U. 1988. Alteration of pulmonary structure by Pseudomonas aeruginosa exoenzyme S. J. Med. Microbiol. 26: 133-141.
27. Woods, D.E., To, M., and Sokol, P.A. 1989. Pseudomonas aeruginosa exoenzyme S as a pathogenic determinant in respiratory infections. Antibiot. Chemother. 42: 27-35.